Igcl 0.25mg Tablet
Marketer
IGP Mediventures Pvt Ltd
Salt Composition
Clonazepam (0.25mg)
Overview Igcl 0.25mg Tablet
Clonazepam 0.25mg tablets are a prescription medication for managing epilepsy (seizures) and anxiety. This medication reduces excessive neuronal activity, promoting brain calmness. It can be administered with or without food, but consistent daily timing ensures stable blood levels. Always follow your doctor's prescribed dosage and duration; this medication has a high potential for dependence. If a dose is missed, take it immediately upon recall; complete the entire course, even with symptom improvement. Abrupt cessation is dangerous and should only occur under medical supervision, as it can trigger increased seizure frequency and potentially cause nausea, anxiety, flu-like symptoms, and myalgia. Common side effects include fatigue, depression, and impaired motor control. Drowsiness and dizziness are also possible; avoid driving or tasks requiring concentration until effects are known. Report any unusual mood changes or depressive symptoms promptly to your doctor, as suicidal ideation is a potential risk.
Uses of Igcl 0.25mg Tablet
Managing anxiety and epileptic seizures
Major Benefits of Igcl 0.25mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or breaking it. The 0.25mg Igcl tablet can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Igcl 0.25mg Tablet:
- Depression
- Dizziness
- Drowsiness
- Fatigue
- Impaired coordination
- Memory impairment
How to use Igcl 0.25mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. The 0.25mg Igcl tablet can be consumed with or without food, although consistent timing is recommended.
How Igcl 0.25mg Tablet works:
Igcl 0.25mg tablets contain a benzodiazepine that enhances the effects of GABA, a neurotransmitter. This action reduces heightened, irregular neuronal firing in the brain.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Igcl 0.25mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Igcl 0.25mg tablets during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional circumstances involving a life-threatening condition, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
Administration of Igcl 0.25mg tablets during lactation presents minimal risk. Research in human subjects indicates negligible transfer of the medication into breast milk, posing no appreciable threat to the infant.
DrivingUNSAFE
Taking a 0.25mg Igcl tablet may impair driving ability due to potential side effects.
KidneyCAUTION
Patients with kidney impairment should use 0.25mg Igcl tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. In individuals with end-stage renal disease, 0.25mg Igcl tablets may induce pronounced somnolence.
LiverCAUTION
Patients with liver impairment should use 0.25mg Igcl tablets cautiously, potentially requiring a modified dosage. Physician consultation is advised.
What if you forget to take Igcl 0.25mg Tablet :
Should you forget to take your Igcl 0.25mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Igcl 0.25mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzodiazepine Analogs |
| Developing Habits | Affirmative. |
| Type of Treatment | Neuroscience of the Central Nervous System |
| Action Class | Benzodiazepine medications |


